The FDA has begun soliciting feedback to inform the next version of the Prescription Drug User Fee Act. User fees remain ...

Audio Interview from the New England Journal of Medicine — Interview with Tom Frieden on the role of the CDC and current threats to the U.S. public health infrastructure.

A man from rural India presented with redness and blurry vision in one eye. Examination was notable for panuveitis and a live worm in the posterior segment; the worm was removed in a pars plana vit ...

“Corporatization” of health care, a process predicted decades ago, now refers to the general trend throughout the industry ...

The author describes the scientific foundations of a clinical trial of a first-in-class small-molecule estrogen receptor degrader to treat patients with metastatic breast cancer.

The rising tide of chronic kidney disease among patients with type 2 diabetes continues to challenge clinicians and health systems worldwide.1 Advances have been made in the management of chronic k ...

Though infant mortality has continuously been targeted by health policy agendas, policies tend to place it in an individualistic and narrow frame, failing to consider and address its structural dri ...

To the Editor: In the 2IQP trial, Kudva and colleagues (May 8 issue) 1 found that in adults with insulin-treated type 2 diabetes, automated insulin delivery (AID) led to a greater reduction in ...

The need to suppress a patient’s immune system after the transplantation of allogeneic cells is associated with wide-ranging side effects. We report the outcomes of transplantation of ...

Explore this issue of The New England Journal of Medicine (Vol. 393 No. 5).

The former members of the Advisory Committee on Immunization Practices consider paths forward for U.S. vaccine policy in the wake of their dismissal by the Secretary of Health and Human Services in ...

How much is enough in the treatment of newly diagnosed multiple myeloma? As clinicians, we want to provide efficacious treatments for our patients to avoid undertreating them. However, we also want ...